Tablets & Capsules

TC0515

Issue link: https://www.e-digitaleditions.com/i/507774

Contents of this Issue

Navigation

Page 33 of 49

HEAD OFFICE GERMANY: www.meggle-pharma.de service.pharma@meggle.de Phone +49 8071 73 476 MEGGLE USA: www.meggle-pharma.com customer.service@meggle.com Phone +1 844 4MEGGLE (+1 844 463 4453) MEGGLE's world's first high-functionality triple co-processed excipient is a monodisperse combination of alpha-lactose monohydrate, MCC and starch. It is specifically designed to ease oral solid dosage form development and manufacture and highly appropriate for direct compression (DC). The benefits speak for themselves. And for CombiLac ® : CombiLac ® . Best of both: compactibility and disintegration. From Meggle. – Excellent compactability – Excellent flowability – Fast, hardness-independent tablet disintegration for effective API release – Low friability – Overcoming individual ingredient compacting and handling limitations CombiLac ® from MEGGLE: Combining best of both. Certifi ed

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0515